Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN EBITDA Margin
EBITDA as a percentage of revenue.
Ryan Specialty Holdings, Inc.NYSE: RYAN
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin narrows to 27.9%
EBITDA Margin was 27.9% in Q2 FY2026, down 3.5 pp from a year earlier. On a trailing-twelve-month basis it was 24.5%, down 1.5 pp year over year. Over 3 fiscal years it widened by 3.5 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 30.7% for the fiscal year ending Dec 2026, up from 26.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 27.9%+6.5 pp QoQ
- Last fiscal yearDec 2025
- 26.3%+2.5 pp YoY
- LTMJun 2026
- 24.5%-1.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -3.5 pp | +3.5 pp | +7.0 pp |
| 1 year | +2.5 pp | +4.4 pp | +1.8 pp |
| 3 years | +3.5 pp | +2.2 pp | -1.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 26.3%
- Year-over-year change
- +2.5pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.3% | +2.5pp |
| FY2024 | 2024-12-31 | 23.8% | +1.0pp |
| FY2023 | 2023-12-31 | 22.8% | -0.0pp |
| FY2022 | 2022-12-31 | 22.8% | +5.1pp |
| FY2021 | 2021-12-31 | 17.7% | — |
EBITDA Margin vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's LTM Jun 2026 EBITDA Margin of 24.5% is the 7th highest of the 9 companies compared; the peer median is 28.2%.
- Its year-over-year change of -1.5 pp is the 7th highest of 9, against a peer median of +3.8 pp.
- Over three fiscal years its change of +3.5 pp compares with a peer median of -4.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 62.3% | -4.3 pp | -30.7 pp | |
| LTM Sep 2026 | 56.9% | -25.0 pp | -21.7 pp | |
| LTM Jun 2026 | 39.5% | +14.1 pp | +56.2 pp | |
| LTM Jun 2026 | 29.2% | +5.5 pp | +9.0 pp | |
| LTM Sep 2026 | 27.3% | +2.7 pp | -13.7 pp | |
| LTM Jun 2026 | 25.2% | -0.0 pp | -6.8 pp | |
| LTM Jun 2026 | 24.5% | -1.5 pp | +3.5 pp | |
| LTM Sep 2026 | 19.2% | +5.0 pp | +8.4 pp | |
| LTM Jun 2026 | 16.3% | +7.8 pp | -2.4 pp | |
| Peer median (excluding RYAN) | 28.2% | +3.8 pp | -4.6 pp | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.73B | 2.08B | 2.52B | 3.05B |
| Cost of Revenue | 0 | 0 | 0 | 0 | 287.52M |
| Gross Profit | 1.43B | 1.73B | 2.08B | 2.52B | 2.76B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 90.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.13B | 1.33B | 1.6B | 1.94B | 453.45M |
| Operating Expenses | 1.37B | 1.55B | 1.84B | 2.24B | 2.14B |
| Depreciation & Amortization | 112.68M | 109.29M | 115.84M | 167.63M | 287.52M |
| EBITDA | 253.6M | 393.31M | 473.27M | 598.63M | 803.08M |
| EBITDA Margin | 17.7% | 22.8% | 22.8% | 23.8% | 26.3% |
| Operating Income | 61.56M | 179.19M | 237.93M | 272.55M | 625.23M |
| Operating Margin | 4.3% | 10.4% | 11.5% | 10.8% | 20.5% |
| Interest Income | 0 | 0 | 0 | 0 | 56.54M |
| Interest Expense | 79.35M | 104.83M | 119.51M | 158.45M | 222.38M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (332.05M) |
| Income Before Tax | 61.56M | 179.19M | 237.93M | 272.55M | 293.18M |
| Pre-Tax Margin | 4.3% | 10.4% | 11.5% | 10.8% | 9.6% |
| Income Tax Expense | 4.93M | 15.94M | 43.45M | 42.64M | 79.03M |
| Net Income | 65.87M | 61.05M | 61.04M | 94.67M | 63.4M |
| Net Margin | 4.6% | 3.5% | 2.9% | 3.8% | 2.1% |
| EPS (Basic) | (0.07) | 0.56 | 0.57 | 0.78 | 0.50 |
| EPS (Diluted) | (0.07) | 0.52 | 0.52 | 0.71 | 0.47 |
| Weighted Avg Shares | 105.73M | 108.62M | 114.36M | 120.78M | 127.27M |
| Weighted Avg Shares (Diluted) | 105.73M | 265.75M | 125.75M | 274.84M | 278.51M |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.